Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0029463 (
osteosarcoma
)
16,637
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Multidrug resistance to anti-cancer agents (MDR) is a major barrier to successful cancer treatment. Current knowledge about genes that contribute to MDR is limited, however, and its mechanisms remain unclear. To identify genes involved in MDR, we performed differential display analysis and isolated a novel human gene,
RB1CC1
(RBI-inducible Coiled-Coil 1). The 6.6-kb
RB1CC1
cDNA encodes a putative 1594-amino-acid protein that contains a nuclear localization signal, a leucine zipper motif and a coiled-coil structure. Western blot analysis and immunocytochemical staining with anti-
RB1CC1
antibody showed that endogenously expressed
RB1CC1
protein localized to the nucleus. In MDR variants of human
osteosarcoma
cells,
RB1CC1
expression increased in response to doxorubicin-induced cytotoxic stress and remained elevated for the duration of drug treatment.
RB1CC1
expression levels correlated closely with those of RB1 (retinoblastoma 1) in cancer cell lines as well as in various normal human tissues. Moreover, introduction of wild-type
RB1CC1
significantly induced RB1 expression in human leukemic cells. These data suggest that
RB1CC1
may be a key regulator of RB1 gene expression.
...
PMID:Identification of RB1CC1, a novel human gene that can induce RB1 in various human cells. 1185 Aug 49
Multidrug resistance (MDR) to anticancer agents is a major barrier to the successful treatment of human osteosarcomas. Current understanding of the genes that contribute to the features of MDR is limited, and the mechanisms remain unclear. Here we applied differential display reverse transcription-polymerase chain reaction (DDRT-PCR) to parental and MDR-variants of U-2 OS human
osteosarcoma
cells, to clarify the genes involved in the MDR cells, and identified five candidate genes. These are BCRP (breast cancer resistance protein) encoding a transmembrane efflux pump;
RB1CC1
(RB1-inducible coiled-coil 1), a tumor suppressor regulating RB1 (retinoblastoma 1) expression; a novel transcriptional variant of dUTPase; SSR2 (beta-signal sequence receptor), which is associated with protein translocation across ER membrane; and HSP105 encoding high molecular mass heat shock proteins. Molecular and biological characterization of these genes will yield further insight into the features between MDR and tumor progression in human osteosarcomas.
...
PMID:Differentially expressed genes in multidrug resistant variants of U-2 OS human osteosarcoma cells. 1513 64